Pier Capital’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.47M | Sell |
396,304
-31,839
| -7% | -$359K | 0.68% | 72 |
|
|
2025
Q1 | $4.32M | Buy |
428,143
+5,413
| +1% | +$54.6K | 0.72% | 69 |
|
|
2024
Q4 | $5M | Sell |
422,730
-7,178
| -2% | -$84.9K | 0.71% | 79 |
|
|
2024
Q3 | $4.96M | Buy |
429,908
+4,821
| +1% | +$55.6K | 0.7% | 80 |
|
|
2024
Q2 | $4.49M | Buy |
425,087
+96,905
| +30% | +$1.02M | 0.67% | 77 |
|
|
2024
Q1 | $3.46M | Sell |
328,182
-3,085
| -0.9% | -$32.5K | 0.48% | 90 |
|
|
2023
Q4 | $3.72M | Sell |
331,267
-3,736
| -1% | -$42K | 0.53% | 88 |
|
|
2023
Q3 | $3.91M | Sell |
335,003
-279,932
| -46% | -$3.27M | 0.63% | 79 |
|
|
2023
Q2 | $6.2M | Sell |
614,935
-1,004
| -0.2% | -$10.1K | 0.89% | 58 |
|
|
2023
Q1 | $4.55M | Buy |
+615,939
| New | +$4.55M | 0.69% | 73 |
|